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Dopamine neurons in the ventral tegmental area
(VTA) play an important role in the motivational sys-
tems underlying drug addiction, and recent work
has suggested that they also release the excitatory
neurotransmitter glutamate. To assess a physio-
logical role for glutamate corelease, we disrupted
the expression of vesicular glutamate transporter 2
selectively in dopamine neurons. The conditional
knockout abolishes glutamate release frommidbrain
dopamine neurons in culture and severely reduces
their excitatory synaptic output in mesoaccumbens
slices. Baseline motor behavior is not affected,
but stimulation of locomotor activity by cocaine is
impaired, apparently through a selective reduction
of dopamine stores in the projection of VTA neurons
to ventral striatum. Glutamate co-entry promotes
monoamine storage by increasing the pH gradient
that drives vesicular monoamine transport. Remark-
ably, low concentrations of glutamate acidify syn-
aptic vesicles more slowly but to a greater extent
than equimolar Cl, indicating a distinct, presynaptic
mechanism to regulate quantal size.
INTRODUCTION
Formany neurons, the neurotransmitter they release is a defining
feature. Release of a monoamine such as dopamine suggests
a role for the cell in neuromodulation, glutamate a role in excita-
tion, and GABA in inhibition. However, it has become clear that
many neurons also release a classical transmitter other than
the one with which they are usually associated. Inhibitory
neurons in the spinal cord and brainstem release both glycine
andGABA (Awatramani et al., 2005; Jonas et al., 1998; Nabekura
et al., 2004), although this is not surprising since they are both
inhibitory and a single carrier transports both into synaptic vesi-
cles (Wojcik et al., 2006). On the other hand, seizure activity
enables hippocampal mossy fibers to release GABA as wellas glutamate (Gutie´rrez, 2000), transmitters with generally
opposing actions in adulthood.
A number of observations suggest that neurons releasing the
neuromodulatory monoamines can also release the excitatory
transmitter glutamate. In single-cell (autaptic) cultures, sero-
tonin, and dopamine neurons form glutamatergic synapses onto
themselves (Johnson, 1994; Sulzer et al., 1998). Supporting the
physiological relevance of these observations, stimulation of
the ventral tegmental area (VTA) in horizontal brain slices elicits
a monosynaptic excitatory postsynaptic current (EPSC) in
nucleus accumbens (NAc) medium spiny neurons (Chuhma
et al., 2009; Chuhma et al., 2004). In addition, stimulation of
the VTA in anesthetized rats leads to monosynaptic glutamater-
gic EPSCs in pyramidal neurons of the prefrontal cortex (PFC)
(Lavin et al., 2005). However, uncertainty has remained about
the dopaminergic origin of this input to both striatum and cortex,
which receive abundant glutamatergic input from other sources.
The corelease of glutamate predicts that dopamine neurons
have the machinery required for exocytotic release of this
excitatory transmitter. All cells contain glutamate for its role in
protein synthesis and metabolism, but the vesicular glutamate
transporters (VGLUTs) are specifically required for exocytotic
release (Reimer and Edwards, 2004; Takamori, 2006). Indeed,
the expression of three VGLUT isoforms appears to account
for the glutamatergic phenotype of most neuronal populations
demonstrated to use glutamate as a transmitter. In addition,
the VGLUTs have a largely complementary distribution, with
VGLUT1+ neurons in cerebral cortex and hippocampus
and VGLUT2+ neurons in thalamus, midbrain, and hindbrain.
VGLUT3 is generally expressed by populations considered to
release a different transmitter, such as cholinergic interneurons
of the striatum and serotonin neurons in the raphe (Fremeau
et al., 2004).
In addition, several catecholamine populations express
VGLUT2. Cultured dopamine neurons express high levels of
VGLUT2, consistent with the corelease of glutamate in vitro
(Dal Bo et al., 2004). In vivo, a subset of VTA dopamine neurons
also expresses VGLUT2 mRNA by in situ hybridization (Be´rube´-
Carrie`re et al., 2009; Dal Bo et al., 2008; Kawano et al., 2006), but
see also (Yamaguchi et al., 2007). Furthermore, single-cell
RT-PCR detects VGLUT2 transcripts in 25% of dopamine
neurons in the mouse midbrain at birth, with this proportionNeuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc. 643
CA
B +/+ Δ/Δ
merge
YFP TH
TH
GFP
merge
VGLUT2VGLUT2
mergeVGLUT2-EGFP
cKO
Figure 1. Histochemical Analysis of VGLUT2-EGFP BAC Transgenic
Mice and the Conditional VGLUT2 Knockout
(A) Sections through the ventral midbrain of VGLUT2-EGFP BAC transgenic
mice were immunostained for EGFP (green) and TH (red). The region of the
VTA in the white box (above) is magnified in the images below. Many TH+
neurons do not express EGFP and several EGFP+ neurons do not contain
TH, but a subset of TH+ cells do also express EGFP. Size bar above indicates
200 mm, below 50 mm.
(B) Immunostaining of wild-type mouse brain (+/+, left) shows VGLUT2 immu-
noreactivity absent from the unconditional knockout (D/D).
(C) Immunofluorescence for YFP (green) and TH (red) in coronal brain sections
from the VTA of a cKOmouse (with Cre recombinase under control of the DAT
gene promoter both inactivating VGLUT2 and driving expression of YFP from
the (Gt)Rosa26Sor floxed-stop reporter) shows that the vast majority of YFP+
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ergic and noradrenergic cell groups in the medulla also express
VGLUT2 (Stornetta et al., 2002). However, the physiological
role of glutamate release by catecholamine neurons remains
unknown.
Previous work has suggested that uptake of an anion can
promote filling with a cationic transmitter by influencing the H+
electrochemical gradient (DmH
+) that drives uptake. DmH
+
produced by the vacuolar H+-ATPase can be expressed as
a chemical gradient (DpH), membrane potential (DJ), or both.
The entry of anions dissipates DJ, thereby activating the H+
pump to produce greater DpH. In particular, Cl entry through
the intracellular subset of ClC family carriers and perhaps even
through the VGLUTs is generally thought to dissipate the DJ
of endosomes and lysosomes as well as synaptic vesicles,
thereby promoting DpH (Accardi and Miller, 2004; Jentsch
et al., 2005; Picollo and Pusch, 2005; Schenck et al., 2009).
The anions ATP and glutamate can also stimulate vesicle filling
by serotonin and acetylcholine, respectively (Bankston and
Guidotti, 1996; Gras et al., 2008). However, the relative role of
different anions in vesicular monoamine transport remains
unknown.
To determine whether dopamine neurons corelease glutamate
in vivo and to assess its physiological role, we have generated
a conditional knockout (cKO) mouse that lacks VGLUT2 specif-
ically in these cells. We find that the loss of VGLUT2 in dopamine
neurons reduces the locomotor response to cocaine, apparently
by reducing vesicular storage of dopamine in the ventral stria-
tum. We also find that glutamate stimulates vesicular mono-
amine transport despite substantial, physiological concentra-
tions of Cl. Indeed, our observation that low concentrations of
glutamate acidify synaptic vesicles to a greater extent and with
different properties than equimolar Cl suggests a presynaptic
mechanism to regulate quantal size.RESULTS
VGLUT2 localizes almost exclusively to synaptic vesicles and
hence to nerve terminals, making it difficult to identify the cell
bodies which express VGLUT2 by immunostaining. To circum-
vent this problem, we used bacterial artificial chromosome
(BAC) transgenic mice expressing enhanced green fluorescent
protein (EGFP) under the control of VGLUT2 regulatory
sequences (Gong et al., 2003). Since EGFP is a soluble protein,
it fills the cell bodies of neurons which express it, and the BAC
transgenic mice exhibit appropriate expression of the EGFP
reporter in the cell populations well established to express
endogenous VGLUT2 (data not shown). We therefore used adult
VGLUT2-EGFPmice to assess expression of VGLUT2 bymature
midbrain dopamine neurons. Figure 1A shows that although
many VTA neurons labeling for tyrosine hydroxylase (TH) do
not express EGFP, and some EGFP+ neurons do not contain
TH (Yamaguchi et al., 2007), a substantial number of neuronsneurons coexpress TH, demonstrating the specificity of recombination.
The merged image below shows a magnification of the boxed areas above.
Size bar, 200 mm. See also Figure S1.
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Figure 2. The Selective Deletion of VGLUT2 fromDopamine Neurons
Eliminates Glutamatergic Currents Observed in Autaptic Cultures
(A) Postnatal midbrain cultures from control and cKO mice were grown on
a glial monolayer and immunostained for YFP (green) and TH (red). The
almost complete colocalization indicates that CreR has mediated recombina-
tion both efficiently and specifically in DA neurons of both cKO and control
mice.
(B) Double staining of the cultures for YFP and VGLUT2 demonstrates that
CreR has eliminated the expression of VGLUT2 by YFP+ dopamine neurons
of cKO but not control mice. Size bars in (A) and (B), 200 mm.
(C) Higher magnification images of double stained cultures show colocaliza-
tion of VGLUT2 with YFP in the synaptic boutons of dopamine neurons from
control but not cKO mice (arrowheads).
(D) A single YFP+ dopamine neuron grown in microculture was recorded in
whole-cell patch-clamp mode. From a holding potential of 60 mV, brief
Neuron
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indicating expression of VGLUT2 mRNA by a subset of VTA
dopamine neurons in vivo (Kawano et al., 2006; Mendez et al.,
2008).
To determine the function of VGLUT2 in midbrain dopamine
neurons, we used homologous recombination in embryonic
stem cells to produce a conditional allele of the mouse
Slc17a6 gene encoding VGLUT2, with exon 2 surrounded by
loxP sites (see Figure S1A available online). After excision of
the positive selectable marker at flanking FRT sites by crossing
to mice that express germ line flp recombinase (Farley et al.,
2000), the resulting VGLUT2+/lox animals were bred to mice
expressing germ line Cre recombinase (Tallquist and Soriano,
2000), excising exon 2 to cause a frameshift that disrupts trans-
lation. Since VGLUT2 knockout mice die immediately after birth
from respiratory failure (Moechars et al., 2006; Walle´n-Macken-
zie et al., 2006), we assessed the loss of VGLUT2 using brains
from homozygous VGLUT2D/D embryos at 14.5–18.5 days gesta-
tion. Cre-mediated recombination eliminated VGLUT2 expres-
sion, as shown by western blot (Figure S1C) and immunohisto-
chemistry (IHC) (Figure 1B). In addition, VGLUT2lox/lox mice
show no difference from wild-type (WT) littermates in brain
VGLUT2 expression (not shown), indicating that the residual
FRT and loxP sites do not interfere with normal expression.
To disrupt VGLUT2 expression specifically in dopamine neu-
rons, we crossed mice containing the conditional VGLUT2+/lox
allele to mice that express Cre recombinase under the control
of regulatory sequences from the Slc6a3 gene that encodes
the plasma membrane dopamine transporter (DAT) (Zhuang
et al., 2005). To assess the specificity of recombination (Fig-
ure 1C) and identify the dopamine neurons with targeted disrup-
tion of the VGLUT2 gene, the mice carried one copy of the Cre-
inducible floxed-stop yellow fluorescent protein (fsYFP) reporter
(Srinivas et al., 2001). For all experiments, we compared control
mice (Slc17a6+/lox; (Gt)Rosa26Sor+/fsYFP; Slc6a3+/cre) to cKO
littermates (Slc17a6lox/lox; (Gt)Rosa26Sor+/fsYFP; Slc6a3+/cre).
cKO mice were born at the expected Mendelian ratios and
showed no obvious difference from littermate controls.VGLUT2 Mediates Glutamate Corelease by Dopamine
Neurons In Vitro and In Vivo
Previous work has shown that dopamine neurons grown in
culture form glutamatergic synapses (Joyce and Rayport, 2000;
Sulzer et al., 1998) and express VGLUT2 (Dal Bo et al., 2004).
To determine whether the loss of VGLUT2 from dopamine
neurons affects glutamate release, we first made postnatal
(P1–P3) midbrain cultures, which contain a high proportion of
tyrosine hydroxylase (TH)-positive dopamine neurons. Double
staining for TH and YFP showed nearly complete colocalization
(Figure 2A), indicating that Cre-mediated recombination had
occurred in all dopamine neurons. We then double stained
for YFP as well as the transporter, observing VGLUT2depolarization to +20 mV induced an unclamped action potential followed
by a fast EPSC in the control (ctrl) but not cKO cell.
(E) The mean excitatory autaptic current differs between control and cKO
dopamine neurons. n = 8–11, ***p < 0.001 by two-tailed t test. Data indicate
means ± SEM.
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Figure 3. Mice Lacking VGLUT2 in Dopamine Neurons Show
Reduced Glutamatergic Currents in NAc Neurons in Response to
VTA Stimulation
(A and B) Glutamatergic responses evoked by stimulation in the VTA were re-
corded from medium spiny neurons in the medial shell of the NAc using 9–11
day (A) and 21–23 day (B) control and cKO mice. Cumulative probability plots
of EPSC amplitudes show that at both ages, a larger proportion of cells from
cKO mice show no or smaller responses than controls. Inset traces show
representative examples of No Response (1), Minimal Response (2), and
Maximal Response (3), with their location on the cumulative probability plot
indicated with numbered open circles. Inset bar graphs of mean amplitudes
from all recorded cells (including those without a response) show a major
reduction in both younger and older cKO mice. The values in parentheses
indicate the number of animals (above) and cells (below). *p < 0.05,
***p < 0.001 in unpaired t test.
(C–E) Glutamate input to YFP+ VTA dopamine neurons does not differ between
P21–24 cKO mice and controls in terms of mean evoked EPSC amplitude (C),
spontaneous EPSC frequency (D), or amplitude (E). Data in bar graphs indicate
mean ± SEM.
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Glutamate Corelease from Dopamine Neurons In Vivoimmunoreactivity at synaptic boutons made by YFP+ dopamine
neurons from control, but not cKO mice (Figures 2B and 2C).
Conditional inactivation of the gene encoding VGLUT2 thus
results in the lossofVGLUT2specifically fromdopamineneurons.646 Neuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc.To determine whether VGLUT2 is required for glutamate
release by dopamine neurons, we produced single-cell cultures
of dopamine neurons that form synapses onto themselves
(autapses), and examined the glutamatergic EPSCs evoked by
brief depolarization. In autapses from control neurons, stimula-
tion evoked EPSCs in 10/11 YFP+ dopamine neurons. However,
EPSCs could not be evoked in any of the eight YFP+ cKO cells
examined (Figures 2D and 2E). The cKO thus eliminates VGLUT2
from dopamine neurons, and at least in vitro, VGLUT2 is required
for the corelease of glutamate by dopamine neurons.
We then used a mesoaccumbens slice preparation to assess
a role for VGLUT2 in glutamate release by dopamine neurons
in vivo. In this preparation, direct stimulation of the VTA elicits
fast, glutamatergic EPSCs in MSNs of the NAc shell (Chuhma
et al., 2004), enabling a distinction between glutamatergic input
originating in the midbrain from abundant glutamatergic projec-
tions originating in cortex and thalamus (Fujiyama et al., 2006).
Using this preparation, we observed a dramatic reduction in
the glutamatergic EPSCs of postnatal day 9–11 (P9–11) cKO
mice relative to control littermates (Figure 3A). Only 2.6%
(1/39) of NAc neurons responded to VTA stimulation with an
EPSC >2 pA in cKO mice, compared to 28% (19/67) of neurons
from controls. Since dopamine neurons from older animals may
express lower levels of VGLUT2 (Be´rube´-Carrie`re et al., 2009;
Mendez et al., 2008), we also examined mesoaccumbens slices
from P21–23 mice. We again observed a major reduction in the
evoked EPSC amplitude in cKO slices relative to controls (Fig-
ure 3B). VTA stimulation produced an EPSC >2 pA in 33%
(15/46) of NAc neurons from control slices, but in only 5.4%
(4/74) of cKO neurons. Since the cKO removes VGLUT2 selec-
tively from dopamine neurons, dopamine neurons from wild-
type mice must both express VGLUT2 and corelease glutamate
in vivo.
In this mesoaccumbens slice preparation, only a minority of
dopaminergic projections remain intact, so EPSCs <2 pA could
reflect either defective glutamate release or the lack of intact
dopamine neuron projections to the recorded MSN. Since we
could not discriminate between these two possibilities, we
included data from all recorded MSNs, including those without
any EPSC (Figures 3A and 3B). It is also important to note that
the littermate controls used for these experiments (Slc17a6+/lox;
Slc6a3+/Cre) had undergone recombination of one VGLUT2 allele
specifically in dopamine neurons and were therefore heterozy-
gous for VGLUT2. Consistent with this, the mean evoked
EPSC amplitude of NAc neurons from these control animals
was 50% that of age-matched mice wild-type at the VGLUT2
locus (Slc17a6+/+; Slc6a3+/Cre) (data not shown).
To assess the specificity of the cKO for VGLUT2 expressed by
dopamine neurons, we examined synaptic input to the VTA,
much of which depends on VGLUT2 (Geisler et al., 2007; Omel-
chenko and Sesack, 2007). Stimulating afferent projections to
the VTA, we found that mean evoked EPSC amplitude in the
midbrain does not differ between control and cKO animals
(Figure 3C). We also observed no significant difference in the
amplitude (Figure 3E) or frequency (Figure 3D) of spontaneous
EPSCs recorded from VTA dopamine neurons. Although the
cKO impairs glutamatergic transmission by dopaminergic effer-
ents, it thus does not affect afferent inputs to these same cells.
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Figure 4. Conditional Knockout Mice Show Reduced Locomotor
Response to Cocaine
(A) Spontaneous locomotor activity over a 72 hr period did not differ between
cKO mice and control littermates (n = 8/genotype; two-tailed t test).
(B) Assessed on the rotarod, motor performance and learning showed no
difference between genotypes by repeated-measures ANOVA (control
n = 13, cKO n = 14).
(C) Naive cKO and control mice were injected with cocaine (20 mg/kg, i.p.) and
locomotor activity monitored over the following hour. cKO mice exhibited
substantially less locomotor activity than controls (control n = 15, cKO n = 16;
**p < 0.01 by Mann-Whitney rank-sum test).
(D) To assess locomotor sensitization, naive mice were injected daily with
cocaine (20 mg/kg i.p.) over 5 consecutive days and again 72 hr after the fifth
injection. cKO mice exhibited less locomotor activity than controls for the first
few cocaine injections. By the fifth injection, however, their response did not
differ significantly from control mice. (control n = 7, cKO n = 8) repeated-
measures ANOVA revealed a significant effect of genotype (p % 0.01) and
a significant effect of treatment (p < 0.001). *p < 0.05, **p < 0.01 by Tukey
post hoc comparison across genotype. Data presented as mean ± SEM.
See also Figure S1.
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Locomotor Activity, Dopamine Storage, and Release
in the Ventral Striatum
To assess the utility of glutamate corelease, we examined
a series of behaviors in cKO mice and littermate controls. Moni-
toring spontaneous activity, cKO animals showed no significant
difference in either novelty-associated locomotion over 4 hr or in
total locomotor activity over the following 3 days (Figure 4A). The
cKO mice also exhibited no significant difference in the ability to
perform or learn an accelerating rotarod task performed daily for
5 days (Figure 4B). Thus, the loss of VGLUT2 from dopamine
neurons does not affect spontaneous activity, coordination or
motor learning.
Cocaine increases extracellular dopamine by inhibiting its
reuptake, stimulating locomotor activity through a mechanism
that depends first on exocytotic dopamine release (Torres
et al., 2003; Uhl et al., 2002). When challenged with 20 mg/kg
cocaine, cKO mice showed significantly less locomotor activity
than littermate controls (Figure 4C). However, repeated dailyinjections with cocaine still elicited behavioral sensitization in
cKOmice, and after several days, locomotor responses became
indistinguishable from controls (Figures 4D and S2A). Despite
the initially reduced effect of cocaine on locomotion, cKO mice
formed a conditioned place preference (CPP) to cocaine, sug-
gesting that at least some forms of reward and associative
learning remain intact (Figures S2B and S2C).
Since cocaine-induced locomotion involves the extracellular
accumulation of dopamine released by exocytosis, the initially
reduced locomotor response might result from reduced vesic-
ular stores. We thus measured striatal dopamine content, which
closely reflects vesicular stores. Although dopamine levels in the
dorsal striatum did not differ between cKO and littermate
controls (Figure 5A), the levels of dopamine and its metabolites
3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic
acid (HVA) all showed a 30%–40% reduction in the ventral stria-
tum (including olfactory tubercle and NAc core as well as shell) of
cKO mice (Figure 5B).
To assess directly the vesicular release of dopamine, we used
fast-scan cyclic voltammetry (FSCV) (Wightman and Zimmer-
man, 1990) to measure the kinetics and amount of dopamine
release evoked by a single action potential in striatal slices.
Due to the heterogeneity of dopaminergic innervation, the results
from three sites in the ventral striatum (specifically, within the
NAc shell) of each slice were measured and averaged. Relative
to control littermates, cKO mice showed a 23% reduction in
the dopamine release evoked by a single action potential in the
ventral striatum, with no change in dorsal striatum (Figures 5C
and 5D).
To assess a potential effect on dopamine reuptake, we exam-
ined the kinetics of release at higher time resolution by amper-
ometry. Similar to FSCV, amperometry showed a reduction in
dopamine release from the NAc shell of cKO mice (28.7 ± 5 pA)
relative to control (52.7 ± 5.4 pA; n = 20/genotype and p < 0.001
by paired two-tailed t test). The rates of dopamine clearance did
not differ significantly between genotypes, but a trend toward
slower clearance (t = 407 ± 34 ms for cKO mice and
354 ± 26 ms for control, n = 20/genotype, p = 0.057 by paired
t test) argues against increased clearance as a mechanism for
reduced release in the slice.
To determine whether changes in dopamine production or
terminal density might account for these differences, we quanti-
fied expression of the biosynthetic enzyme TH by fluorescent
western analysis. The ventral striatum of cKO and control mice
showed no difference in the amount of TH protein (Figure S3A).
We also assessed functional TH activity in vivo, administering
the aromatic acid decarboxylase (AADC) inhibitor NSD-1015
and measuring the accumulation of L-dopa in the ventral stria-
tum. NSD-1015 increased tissue L-dopa levels as anticipated,
but cKOmice did not differ from controls in L-dopa accumulation
(Figure S3B).
Glutamate Stimulates Monoamine Uptake by VMAT2
Previous work has shown that glutamate uptake increases DpH
across the synaptic vesicle membrane (Cidon and Sihra, 1989;
Maycox et al., 1988). Since uptake by the vesicular monoamine
transporters (VMATs) depends predominantly on DpH (Johnson,
1988), transport of glutamate into the same vesicles might thusNeuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc. 647
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Figure 5. ReducedDopamine Tissue Content and EvokedDopamine
Release in the Ventral Striatum of cKO Mice
(A and B) Tissue monoamine content was measured by HPLC coupled to an
electrochemical detector. Punches from the dorsal striatum (A) showed no
difference across genotype in the levels of dopamine (DA), dopamine metab-
olites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) and
serotonin (5-HT) (n = 10/group). However, DA, DOPAC, and HVA were
significantly reduced in the ventral striatum (B) of cKO mice relative to control
littermates, with no change in 5-HT levels (n = 10/group; *p < 0.05 by two-tailed
t test).
(C and D) The dopamine release evoked by single action potentials was
measured in striatal slices using fast-scan cyclic voltammetry (FSCV). (C)
The traces show representative examples of evoked dopamine release and
reuptake in the ventral striatum. (D) The ventral striatum (NAc shell) of cKO
mice released less dopamine than controls, but the two genotypes did not
differ in the dorsal striatum. (n = 9 mice and 29 paired slices per genotype
for dorsal striatum, 10 mice and 34 paired slices per genotype for ventral
striatum). **p < 0.01 by two-tailed, paired t test. Data indicate mean ± SEM.
See also Figure S2.
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Figure 6. Glutamate Cotransport Stimulates Monoamine Uptake
into Synaptic Vesicles
(A and B) Synaptic vesicles (SV) prepared from rat ventral striatum were immu-
noprecipitated (IP) with antibodies to synaptophysin (syp), VGLUT2, VMAT2,
Golgi matrix protein GM130, or no primary antibody, and the isolated vesicles
immunoblotted for VMAT2 (A) and VGLUT2 (B). Relative to the other samples,
one-tenth of the indicated samples was immunoblotted to avoid saturation
of the signal. Antibodies to VGLUT2 isolated SVs containing VMAT2 (A) and
antibodies to VMAT2 isolated vesicles containing VGLUT2 (B), with minimal
or no isolation in the absence of antibodies or with antibodies to GM130.
(C) The uptake of 3H-5-HT was measured over 5 min in membranes from
HEK293 cells transiently expressing VMAT2 with or without VGLUT2. (3H-5-
HT was used for these experiments because VMAT2 recognizes all the mono-
amine transmitters and 5-HT is more stable than the catecholamines.) Relative
to aspartate, which is not recognized by the VGLUTs and has no effect on
monoamine uptake (data not shown), equimolar glutamate (10 mM) stimulated
transport in the presence, but not the absence, of VGLUT2, and reserpine
(10 mM) largely eliminated the activity.
(D) Monoamine uptake was measured over 10 min using synaptic vesicles
from rat ventral striatum. Glutamate (10 mM) stimulated monoamine uptake
relative to aspartate in the presence of 2 mM Cl (left). Increasing Cl concen-
tration from 2 to 20 mM also stimulated monoamine uptake in the absence of
glutamate (middle). Despite the sensitivity of VMAT activity to Cl, glutamate
stimulates monoamine uptake even at higher, physiological concentrations
of Cl (20 mM) (right). **p < 0.01; ***p < 0.001 by two-tailed t test. Data
presented as means ± SEM.
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Glutamate Corelease from Dopamine Neurons In Vivobe expected to stimulate monoamine uptake. The loss of gluta-
mate transport in VGLUT2 cKO mice may therefore account for
the reduced dopamine content in ventral striatum (Figure 5B).
However, this mechanism requires that VMAT2 and VGLUT2
localize to an overlapping population of synaptic vesicles.
To assess the colocalization of VGLUT2 with VMAT2 on
synaptic vesicles, we performed immunoisolations using a light
membrane fraction from the ventral striatum. We used rats for
these experiments due to the greater availability of tissue and
the limited cross-reactivity of several antibodies for mouse
proteins. As anticipated, antibodies to the ubiquitous synaptic
vesicle protein synaptophysin isolated significant amounts of
VMAT2 (Figure 6A). Antibodies to VGLUT2 also precipitated
most of the VMAT2 immunoreactivity, indicating that many of
the VMAT2+ vesicles also contain VGLUT2. An antibody to Golgi
matrix protein GM130, as well as controls lacking a primary
antibody, failed to precipitate VMAT2, demonstrating the speci-
ficity of the immunoisolation. Reciprocal experiments using
antibodies to VGLUT2 and synaptophysin also isolated large
amounts of VGLUT2 (Figure 6B). VMAT2 antibodies isolated
more VGLUT2 than negative controls, but the efficiency of648 Neuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc.VGLUT2 immunoisolation by VMAT2 appears low, presumably
because most VGLUT2 in the ventral striatum originates in the
thalamus (Fujiyama et al., 2006), which does not express VMAT2.
To determine whether glutamate cotransport has the potential
to stimulate monoamine uptake, we examined the effect of
VGLUT2 coexpression on VMAT2 activity. In HEK293 cell mem-
branes expressing both transporters, the addition of 10 mM
glutamate stimulated monoamine uptake 15% relative to
10 mM aspartate (Figure 6C), which is not recognized by
VGLUTs (Naito and Ueda, 1985; Takamori, 2006). We then
examined the effect of glutamate on monoamine uptake by
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Figure 7. Chloride and Glutamate Acidify Synaptic Vesicles through
Distinct Mechanisms
The quenching of acridine orange fluorescence was used to assess synaptic
vesicle DpH in response to the addition of ATP and other anions.
(A) The traces show representative responses to the sequential addition of
1mMATP, 2mMCl (to provide allosteric activation of the VGLUTs) and either
4 mM Cl (Cl, blue), glutamate (glut, red) or aspartate (asp, black). Bafilomy-
cin (baf, 250 nM) inhibits the vacuolar H+-ATPase and allows dissipation of
DpH. Under these conditions, glutamate produced greater acidification than
equimolar Cl, and aspartate had no effect. In addition, vesicles acidified
with glutamate lost DpH more slowly in response to bafilomycin than those
acidified with Cl.
(B) Anion-induced acidification was fit to a single exponential and the
maximum change in fluorescence (DF) extrapolated. Although glutamate
produced greater acidification at low concentrations, Cl acidified to a greater
extent at high concentrations (>10 mM).
(C) Fitting to a single exponential was also used to derive Initial rates of acid-
ification (Vo DF/t). Cl acidifies more rapidly than glutamate, particularly at
anion concentrations >4mM. Data presented asmeans ± SEM. The sequential
(D) or simultaneous (E) addition of 4 mM glutamate produced greater acidifica-
tion than 20 mM Cl alone.
(F) Synaptic vesicles acidified to approximately the same extent with either
4 mM glutamate or 14 mM Cl, but the vesicles acidified with glutamate lost
DpH much more slowly in response to bafilomycin than those acidified with
Cl.
Neuron
Glutamate Corelease from Dopamine Neurons In Vivosynaptic vesicles from the ventral striatum (including olfactory
tubercle, NAc core and shell). Again, glutamate stimulated
monoamine uptake into native synaptic vesicles 20% relative
to aspartate (Figure 6D), providing additional functional evidence
for the colocalization of a VGLUT with VMAT2. Since only
a fraction of dopamine synapses are likely to contain VGLUT2
(Be´rube´-Carrie`re et al., 2009; Kawano et al., 2006; Mendez
et al., 2008), the effect of glutamate on monoamine storage
that we observe may underestimate the full effect on those
vesicles that contain both transporters.
Synaptic Vesicles Acidified with Glutamate or Chloride
Differ in the Magnitude and Stability of DpH
Both glutamate and Cl appear to increase DpH by dissipating
DJ, thereby reducing the efflux of H+ driven by membrane
potential and/or secondarily activating the H+ pump. Glutamate
may thus stimulate monoamine uptake through a mechanism
redundant with Cl. Indeed, Cl occurs at substantially higher
concentrations than glutamate in most cells. To determine
whether glutamate and Cl differ in their uptake by synaptic vesi-
cles, we monitored vesicle acidification using acridine orange,
a dye quenched at low pH (Schuldiner et al., 1972). Since Cl
and glutamate have both been shown to acidify synaptic vesicles
from the whole brain, we used this mixed population due to the
large amount of material required for these studies. Adding
ATP to activate the H+ pump, we observed relatively little acidi-
fication in the absence of an anion. Because VGLUT activity
depends on allosteric activation by low concentrations of Cl,
we then added 2 mM Cl, a concentration that produces rela-
tively little acidification on its own. The subsequent addition of
either Cl or glutamate caused a greater increase in acidification
(Figure 7A). At low concentrations, however, glutamate pro-
duced much more acidification than equimolar Cl (Figures 7A
and 7B). Indeed, as little as 0.125 mM glutamate increased
DpHmore than 4mMCl. On the other hand, increasing concen-
trations of Cl caused progressively greater increases in DpH,
whereas the effects of glutamate saturated at 3–5 mM (Fig-
ure 7B), consistent with the known Km of VGLUTs (1–3 mM;
Fremeau et al., 2004; Takamori, 2006). High concentrations of
Cl thus increase DpH more than high concentrations of gluta-
mate. The kinetics of acidification also differed between the
two anions. Although low concentrations of glutamate acidified
to a greater extent than equivalent concentrations of Cl, Cl
acidified faster even at these low concentrations, and the
difference in rate was more apparent at high concentrations
(Figure 7C). Since recent work at the calyx of Held has demon-
strated that the concentration of Cl at the nerve terminal can
reach 20 mM (Price and Trussell, 2006), we also tested the
ability of 4 mM glutamate to acidify vesicles in the presence of
20 mM Cl. We found that glutamate acidifies synaptic vesicles
even after the addition of 20 mM Cl (Figure 7D). Glutamate also
has a clear effect on peak DpH when added simultaneously with
Cl (Figure 7E). However, the decline in DpH that followed this
peak was less pronounced in vesicles acidified with glutamate
than in those acidified with Cl (Figure 7E), suggesting that the
anion responsible for acidification influences the stability ofDpH.
To assess specifically the role of the anion in DpH stability, we
took advantage of the vacuolar H+-ATPase inhibitor bafilomycin.When bafilomycin inhibits the H+ pump, DpH immediately starts
to collapse, enabling us to compare the rate of collapse for
synaptic vesicles acidified with Cl versus glutamate. Since
Cl and glutamate acidify to differing extents, we used concen-
trations of each that produce equivalent peak DpH (Figure 7F).
After acidification with 14 mM Cl, the addition of bafilomycin
rapidly dissipated DpH, as anticipated. However, bafilomycin
produced a much slower alkalinization of synaptic vesiclesNeuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc. 649
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Figure 8. Membrane Potential Limits Proton Efflux in Vesicles Acid-
ified by Glutamate
(A and B) Synaptic vesicles in 140 mM choline gluconate/10 mM K gluconate/
10 mMHEPES (pH 7.4) were acidified by the sequential addition of ATP, 2 mM
Cl, and then either 14 mM Cl (A) or 4 mM glutamate (B). The traces in black
indicate vesicles without any further addition. At the arrow indicated baf/val,
250 nM bafilomycin (red) or 50 nM valinomycin (gray) or both (light red) were
added. The potassium ionophore valinomycin accelerates the dissipation of
DpH by bafilomycin to a much greater extent in vesicles acidified with gluta-
mate than with Cl.
(C) Data from the first 60 s after baf/val addition were fit to either a straight line
(no treatment or val) or single exponential (baf or val + baf) to derive initial rates
of alkalinization (Vo DF/t). Within every condition tested, Cl-acidified vesicles
alkalinized significantly faster than those acidified by glutamate (p < 0.05 by
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650 Neuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc.acidified with 4 mM glutamate (Figure 7F). For equivalent acidifi-
cation, glutamate thus produces a more stable DpH than Cl.
This effect presumably accounts for the slower decline in DpH
observed after peak acidification even with an active H+ pump
(Figures 7E and 7F).
The differential stability of DpH in vesicles acidified with Cl
and glutamate might reflect either differences in buffering by
the two anions or differences in the mechanism of anion flux.
The much higher pKa of glutamate (4.3) than Cl (9) suggests
that glutamate may delay alkalinization simply by acting as
a buffer for vesicle pH after inhibition of the H+ pump. On the
other hand, dissipation ofDpH requires aDJ sufficiently positive
to promote H+ efflux, and since anion efflux produces positive
DJ, differences in the mechanism of anion translocation may
influence the rate of DpH collapse. To distinguish between these
possibilities, we determined whether the imposition of a lumen-
positive DJ accelerates dissipation of DpH. Synaptic vesicles
were acidified in the presence of 10 mM K+ gluconate with
ATP, 2 mM Cl and then either 14 mM Cl or 4 mM glutamate
(Figures 8A and 8B). In vesicles acidified with Cl, the K+ iono-
phore valinomycin had no clear effect on the dissipation of
DpH by bafilomycin (Figure 8A), indicating that the development
of DJ and hence anion efflux did not limit the rate of H+ efflux. In
contrast, valinomycin greatly accelerated the dissipation of DpH
triggered by bafilomycin in vesicles acidified with glutamate
(Figure 8B). Thus, DJ can limit the efflux of H+ from vesicles
acidified with glutamate, suggesting that the mechanism of
anion flux contributes to the stability of DpH. Under all condi-
tions, however, vesicles acidified with glutamate lost DpH
more slowly than those acidified with Cl (Figure 8C), suggesting
that glutamate may also act as a buffer to slow the dissipation
of DpH.
The distinct roles of Cl and glutamate in synaptic vesicle
acidification suggest that glutamate also has a specific role in
the stimulation of monoamine uptake. However, the experiments
demonstrating stimulation of monoamine uptake by glutamate
were performed first with only 2mMCl (Figure 6D), a concentra-
tion sufficient to provide thewell-established allosteric activation
of VGLUTs (Hartinger and Jahn, 1993; Wolosker et al., 1996) but
well below concentrations relevant for the nerve terminal.
Consistent with previous results using synaptic vesicles (Erick-
son et al., 1990), we indeed found that 20 mM Cl produces
a substantial increase in monoamine uptake relative to 2 mM
(Figure 6D). Nonetheless, glutamate stimulated monoamine
uptake at 20 mM Cl to the same extent it does at 2 mM
(Figure 6D), supporting a role for glutamate distinct from Cl.DISCUSSION
VGLUT2 Expression by Dopamine Neurons Confers
Glutamate Release
Despite clear evidence for glutamate corelease by dopamine
neurons in vitro (Joyce and Rayport, 2000; Sulzer et al., 1998),two-tailed t test). The addition of val also accelerated alkalinization under
each condition, with the exception of baf-treated vesicles acidified using Cl
(p < 0.01 by two-tailed t test). Data presented as means ± SEM.
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Glutamate Corelease from Dopamine Neurons In Vivoseveral factors complicate interpretation of the evidence for cor-
elease in vivo. Stimulation of the VTA produces fast, glutamate-
mediated responses in NAc and prefrontal cortex (Chuhma et al.,
2004, 2009; Lavin et al., 2005), but it has remained unclear
whether the released glutamate derives from dopamine neu-
rons or from adjacent, nondopaminergic inputs. Inhibition of
the glutamate response by activation of D2 autoreceptors in
the VTA supports a dopaminergic origin for the released gluta-
mate, but nondopamine neurons of the VTA also express D2
receptors (Margolis et al., 2006; Ungless et al., 2004). Loss of
the glutamate response after lesion with 6-hydroxydopamine
further supports a dopaminergic source for the released gluta-
mate, but this toxin is also not entirely specific for dopamine
neurons, particularly when administered locally at high concen-
trations (Poirier, 1975).
The results described here provide functional evidence using
a conditional genetic approach that the glutamate released by
VTA stimulation derives specifically from dopamine neurons.
Taking advantage of the requirement for VGLUTs in exocytotic
glutamate release, and the nonredundant expression of VGLUT
isoforms by most neurons, we find that the loss of VGLUT2
indeed eliminates glutamate signaling by dopamine neurons
in vitro. In vivo, the use of regulatory sequences from the dopa-
mine transporter gene to drive expression of Cre recombinase
ensures the inactivation of VGLUT2 selectively in dopamine
neurons. Analysis of the cKO mice shows that the loss of
VGLUT2 selectively in dopamine neurons greatly reduces VTA-
evoked excitatory transmission in the NAc shell. Nonetheless,
the cKO does not entirely eliminate the striatal glutamate
response after VTA stimulation. Indeed, a distinct population of
nondopaminergic midbrain neurons also express VGLUT2,
although whether these cells project to nucleus accumbens
remains unknown (Dal Bo et al., 2008; Kawano et al., 2006; Men-
dez et al., 2008; Yamaguchi et al., 2007). Incomplete excision by
Cre recombinase or inadvertent stimulation of passing fibers are
other possibilities. However, the striking effect of the cKO indi-
cates that the expression of VGLUT2 by dopamine neurons
accounts for essentially all of the glutamate release by these
cells.
Despite the clear evidence for VGLUT2-dependent glutamate
release by dopamine neurons, the level of VGLUT2 expression
by these cells appears to be relatively low. In vitro, midbrain
dopamine neurons express high levels of VGLUT2, but this
apparently downregulates as a result of contact with
GABAergic neurons (Mendez et al., 2008). In vivo, previous
studies using in situ hybridization have indicated variable but
generally low levels of VGLUT2 expression by dopamine
neurons. One report described colocalization of VGLUT2 in
5.3%, 21.7%, 52.7% of TH+ neurons in, respectively, the para-
nigral, interfasicular, and rostral linear nuclei (Kawano et al.,
2006), but another study described <1% colocalization
throughout the VTA (Yamaguchi et al., 2007). These discrep-
ancies may simply reflect differences in the regions examined
or the ability to detect low abundance VGLUT2 transcripts.
Indeed, sensitive single-cell RT-PCR shows that 25% of all
midbrain dopamine neurons express VGLUT2 at birth, with this
percentage declining to 14% by P45 (Mendez et al., 2008). Our
results using adult VGLUT2-EGFP BAC transgenic mice nowconfirm the expression of VGLUT2 by a subset of midbrain dopa-
mine neurons in a region of the VTA known to project to the stria-
tum (Ikemoto, 2007). However, it is important to note that we
used an amplification system to detect EGFP, and standard
immunofluorescence suggested that midbrain dopamine
neurons express lower levels of EGFP than other, known gluta-
matergic populations (data not shown).
VGLUT2 Facilitates Vesicle Filling with Dopamine
The cKO mice exhibit normal motor activity and learning, but
show a greatly reduced locomotor response to acute administra-
tion of cocaine. Since cocaine blocks the reuptake of dopamine
released by exocytosis, the reduced effect on locomotion may
simply reflect a decrease in exocytotic release by the cKO.
Indeed, we observed a decline in tissue dopamine content, sug-
gesting a reduction in the storage pool (Fon et al., 1997). Consis-
tent with the preferential expression of VGLUT2 by VTA rather
than substantia nigra neurons (Kawano et al., 2006), the reduc-
tion in dopamine was also observed only in the ventral striatum
(which receives projections from the VTA) rather than dorsal
striatum (which receives projections from the substantia nigra).
Depletion of monoamine stores might have resulted from
increased release, but dopamine metabolites DOPAC and HVA
were lower in the ventral striatum of cKO mice, indicating
decreased rather than increased turnover. Further, we observed
a reduction in the dopamine release evoked by stimulation of
slices from the cKO ventral striatum. Thus, the blunted response
to a single dose of cocaine appears to result from a reduction in
dopamine stores and hence release. Although this mechanism
appears to account for the observations, we cannot exclude
the possibility that the loss of glutamate release from dopamine
neurons contributes to the phenotype.
Despite the reduced dopamine stores and release, cKO mice
increase their locomotor response to repeated administration of
cocaine, indicating that locomotor sensitization does not require
glutamate costorage and release. In addition to this form of plas-
ticity, the cKO mice display normal CPP for cocaine, but this is
not surprising since CPP has been shown to persist despite
more severe, chronic reductions in dopamine storage (Hnasko
et al., 2007; Spyraki et al., 1982; Torres et al., 2003; Uhl et al.,
2002).
As predicted by a role for VGLUT2 in dopamine storage,
immunoisolation experiments show that VMAT2 and VGLUT2
colocalize on a subpopulation of synaptic vesicles from the
ventral striatum, presumably within dopaminergic projections.
Serotonergic neurons also express VMAT2 and innervate the
striatum, but this projection is much more sparse than the dopa-
minergic (Figures 5A and 5B; Zhou et al., 2005), and serotonergic
neurons express VGLUT3 rather than VGLUT2 (Fremeau et al.,
2002; Gras et al., 2002; Scha¨fer et al., 2002), effectively
excluding them as a contaminant in these experiments. The
ability of glutamate (but not aspartate) to stimulate monoamine
uptake by synaptic vesicles from the ventral striatum provides
additional, functional evidence for colocalization of a VGLUT
with VMAT2. However, the expression of VGLUT2 by only a frac-
tion of VTA dopamine neurons (Be´rube´-Carrie`re et al., 2009;
Kawano et al., 2006; Mendez et al., 2008) and the partial segre-
gation of glutamate (or VGLUT2) and TH into different neuronalNeuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc. 651
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Glutamate Corelease from Dopamine Neurons In Vivoprocesses (Descarries et al., 2008; Sulzer et al., 1998) suggest
that the impact of VGLUT2 on monoamine storage by the entire
ventral striatum reflects an even greater effect on the subset of
dopamine neurons (and synaptic vesicles) that actually contain
VGLUT2. Although the physiology (postsynaptic recording and
electrochemistry) was performed in the NAc shell, the biochem-
ical analysis was performed using the entire ventral striatum, and
we do not know whether glutamate corelease and costorage
also occur in olfactory tubercle or NAc core.Glutamate and Chloride Acidify Synaptic Vesicles
through Distinct Mechanisms
How does glutamate entry through VGLUT2 increase mono-
amine storage? The most likely explanation involves an increase
in the driving force for monoamine uptake (DpH) due to the dissi-
pation of DJ and resulting increase in DpH. Indeed, glutamate is
well known to acidify synaptic vesicles (Cidon and Sihra, 1989;
Maycox et al., 1988). Recent work using VGLUT3 knockout
mice has invoked this mechanism to account for the increased
storage of acetylcholine (ACh) by cholinergic interneurons of
the striatum (Gras et al., 2008), since the vesicular ACh trans-
porter, like VMAT2, depends primarily on DpH rather than DJ
(Nguyen et al., 1998). However, the work on VGLUT3 showed
an effect of glutamate on ACh uptake in the presence of 4 mM
Cl (Gras et al., 2008), raising questions about the physiological
relevance for the nerve terminal, which contains much higher Cl
concentrations (20 mM; Price and Trussell, 2006). We now find
that glutamate stimulates monoamine uptake to the same extent
in 2 and 20mMCl, showing that higher concentrations of Cl do
not occlude the effect of glutamate. The two anions may there-
fore acidify synaptic vesicles through distinct, non-redundant
mechanisms.
To assess differences in the acidification of synaptic vesicles
by glutamate and Cl, we used the quenching of acridine orange
fluorescence. Although we used a mixed population of synaptic
vesicles from the whole brain, the properties observed should
pertain to monoamine vesicles since the uptake of monoamine
is stimulated by both anions. Remarkably, low concentrations
of glutamate acidify to a much greater extent than equimolar
Cl. This does not simply reflect the expression of VGLUTs on
more synaptic vesicles than a Cl carrier because high concen-
trations of Cl acidify to a greater extent than glutamate. Indeed,
the effect of glutamate saturates at 4 mM, as expected given
the known VGLUT Km (1–3 mM).
How then can glutamate acidify to a greater extent than Cl?
Although the identity of the Cl carrier on monoamine vesicles
remains unknown, it may belong to the ClC family. In addition
to plasmamembrane Cl channels, the ClC family includes intra-
cellular Cl/H+ exchangers. Work on a bacterial member of the
ClC family has shown that this protein exchanges 1 H+ for
2 Cl (Accardi and Miller, 2004). Mammalian relatives include
ClC-3, -5, and -7, which also behave as Cl/H+ exchangers
(Picollo and Pusch, 2005; Scheel et al., 2005) and in the case
of ClC-7, have been shown to function with the same 2 Cl: 1
H+ stoichiometry as the bacterial protein (Graves et al., 2008).
Assuming that the ClC isoform on monoamine vesicles exhibits
the same coupling stoichiometry, with the associatedmovement652 Neuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc.of +3 charge, the concentration gradient of Cl at equilibrium is
predicted by the equation:
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where R is the gas constant, T the absolute temperature, F Fara-
day’s constant, and the vacuolar H+ pump determines DpH and
DJ. Assuming the H+ pump can generate DmH
+3 in the form of
DpH, DJ, or a combination of both (Johnson et al., 1985; John-
son and Scarpa, 1979),
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Alternatively, Cl may actually enter through VGLUT2 itself.
Previous work has shown that, like other members of the so-
called type I phosphate transporter family (Bro¨er et al., 1998;
Busch et al., 1996), the VGLUTs exhibit a Cl conductance (Bel-
locchio et al., 2000), a finding recently replicated with purified
protein in a reconstituted system (Schenck et al., 2009). Although
we still do not know whether this conductance is actually
a channel, dependence on only DJ would generate a shallower
Cl gradient, as predicted by the Nernst equation:
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Replacing DJ with 2.3 RT/F (3  log10([H+]i/[H+]o) as above,
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We do not know the stoichiometry of ionic coupling for the
VGLUTs, but they have been repeatedly demonstrated to be
driven by DpH (Bellocchio et al., 2000; Tabb et al., 1992; Taka-
mori et al., 2000), strongly supporting a H+ exchangemechanism
despite the primary dependence on DJ. Assuming the
exchange of 1 H+ for 1 glutamate and hence the movement of
+2 charge,
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Again replacing DJ with 2.3 RT/F (3  log10([H+]i/[H+]o),
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For a particular anion gradient, glutamate flux through the
VGLUTs is thus predicted to generate DpH 1.5 units greater
than Cl flux through an intracellular ClC and 3 units greater
than Cl flux through a channel, accounting for the greater acid-
ification of synaptic vesicles by subsaturating concentrations of
glutamate than equimolar Cl. Consistent with an effect of the
anion on equilibrium rather than kinetics, even low concentra-
tions of Cl acidify at least as rapidly as glutamate.
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stability of DpH as well as its magnitude. After maximal acidifica-
tion, synaptic vesicles acidified with Cl show a substantial,
spontaneous decline inDpH. Despite equivalent peakDpH, vesi-
cles acidified with glutamate show a much more stable DpH.
Since these differences might simply reflect differences in the
rate of acidification, with peak DpH achieved later in the case
of glutamate, we acidified vesicles with ATP and either Cl or
glutamate, then inhibited the pump with bafilomycin to assess
the stability of preexisting DpH. Using concentrations of Cl
and glutamate that produce equivalent acidification, vesicles
acidified with glutamate retain DpH much longer than vesicles
acidified with Cl. However, vesicles acidified with the two
anions eventually return to a similarDpH, suggesting a difference
in kinetics rather than thermodynamic equilibrium after inhibition
of the H+ pump.
The rate of DpH dissipation after inhibition of the H+ pump
might be controlled by buffering. The extremely low pKa of HCl
means that even high concentrations of Cl confer essentially
no buffering beyond that provided by membrane protein and
lipids. As a result,DpHmight be expected to decline rapidly after
inhibition of the H+ pump in vesicles acidified with Cl. In
contrast, the glutamate pKa 4.3 predicts protonation of up to
8% at a lumenal pH 5.5 (Miesenbo¨ck et al., 1998; Mitchell
and Ryan, 2004; Sankaranarayanan et al., 2000). With lumenal
glutamate concentrations reaching 100 mM, this predicts low
millimolar concentrations of protonated glutamate. Acidification
with glutamate thus results in concentrations of bound H+ that
exceed those of free H+ (low micromolar) by three orders of
magnitude. However, we find that the imposition of positive
DJ with K+ and valinomycin greatly accelerates the dissipation
of DpH after inhibition of the H+ pump, indicating that DJ limits
the rate of H+ efflux after acidification with glutamate. On the
other hand, even K+ and valinomycin do not increase the loss
of H+ by glutamate-acidified vesicles to the same rate as
Cl-acidified vesicles, suggesting that glutamate may also act
as buffer.
A rate-limiting role for DJ in the stability of DpH after inhibition
of the H+ pump suggests that the mechanism of anion efflux
accounts for the differences between vesicles acidified with
Cl and glutamate. In particular, Cl efflux through a channel
will be opposed only by the development of DJ, driving H+
efflux. In contrast, glutamate efflux coupled to H+ exchange
will also be opposed by the outwardly directed DpH, limiting
the development of DJ and hence H+ efflux. The H+ exchange
mechanism that produces greater DpH at thermodynamic equi-
librium thus also presents a kinetic barrier to the efflux of H+,
stabilizing the DpH that drives VMAT activity and ‘‘locking’’
monoamine inside synaptic vesicles.
EXPERIMENTAL PROCEDURES
BAC Transgenic Mice
Adult (2- to 3-month-old) hemizygous VGLUT2-EGFP BAC transgenic mice
were perfused with cold PBS followed by 4% PFA, the brains removed, post-
fixed overnight in 4% PFA and then cryoprotected in 30% sucrose before
freezing. Floating sections (30–40 mm) were rinsed with PBS containing
0.2% Triton X-100 (PBS-Tx), blocked for at least 1 hr in PBS-Tx containing
4% normal donkey serum, and incubated overnight at 4C in blocking solutionwith rabbit anti-TH (Millipore) and chicken anti-GFP (Invitrogen) antibodies
(both at 1:1000). After washing the next day in PBS-Tx, the sections were incu-
bated for two hours in blocking solution that contained cy3-conjugated
donkey-anti-rabbit and HRP-conjugated donkey-anti-chicken secondary anti-
bodies (Jackson Immunoresearch). The sections were then washed with PBS,
incubated for 10 min with the FITC-conjugated TSA reagent (Perkin-Elmer),
rinsed again with PBS, mounted, dehydrated through escalating alcohols fol-
lowed by xylenes, coverslipped with DPX (Fluka), and imaged on a TE2000E
Nikon inverted epifluorescence microscope with Photometrics Coolsnap
HQ2 CCD camera.
Monoamine Levels and Release
To measure tissue monoamine content, mice were euthanized with CO2, their
brains rapidly removed, cooled, and after cutting 1-mm thick sections,
punches made from ventral or dorsal striatum using a pipette tip cut to
1 mm in diameter. (The ventral striatum includes olfactory tubercle, NAc shell,
and core.) Punches from each hemisphere were frozen on dry ice, stored at
80C, and monoamine content determined by the Vanderbilt CMN/KC
neurochemistry core using HPLC coupled to an electrochemical detector as
previously described (Perez and Palmiter, 2005). Tomeasure L-dopa accumu-
lation, mice were treated with 100 mg/kg (i.p.) NSD-1015 (Sigma), tissue
punches taken 30 min later and processed as described above.
Fast-scan cyclic voltammetry (FSCV) and amperometry were used to
measure evoked dopamine release from coronal sections of the striatum
(300 mm). Slices were allowed to recover for 1.5 hr in oxygenated artificial cere-
brospinal fluid (ASCF, in mM: NaCl 125, KCl 2.5, NaHCO3 26, CaCl2 2.4,
MgSO4 1.3, KH2PO4 0.3, glucose 10) at room temperature, placed in
a recording chamber, and superfused (1 ml/min) with ACSF at 36C. Electro-
chemical recordings and electrical stimulation were performed as previously
described (Zhang and Sulzer, 2003). Briefly, freshly cut carbon fiber electrodes
5 mm in diameter were inserted into either the NAc shell or the dorsal striatum
50 mm into the slice, and stimulation performed every 2 min with a single
pulse using a bipolar stimulating electrode 100 mm from the recording elec-
trode. For FSCV, a triangular voltage wave (400 to +900mV at 280 V/s versus
Ag/AgCl) was applied to the carbon fiber electrode every 100 ms and current
recorded using an Axopatch 200B amplifier (Axon Instrument, Foster City, CA),
with a low-pass Bessel Filter set at 10 kHz, digitized at 25 kHz (ITC-18 board,
Instrutech Corporation, Great Neck, New York). Background-subtracted
cyclic voltammograms identified the released substance as dopamine. The
dopamine oxidation currentwas converted to concentration based upon a cali-
bration of 5 mM dopamine in ACSF after the experiment. For amperometry,
a constant voltage of 600 mV (relative to a reference electrode) was applied
via the Axopatch 200B amplifier, and the current sampled at 5 kHz.
Immunoisolation
Ventral striata (including olfactory tubercle as well as NAc shell and core) from
6-week-old mixed sex Spague-Dawley rats (Charles River) were dissected,
homogenized on ice with a Teflon pestle in (mM) 150 NaCl, 10 HEPES-Tris
(pH 7.4), 1 EGTA, 0.1 MgCl2, 0.2 PMSF, and 1 mg/ml pepstatin A, sedimented
at 20,000 3 g for 10 min at 4C and the supernatant sedimented again at
27,0003 g for 10 min. The resulting supernatant (starting material) was frozen
in liquid N2, and stored at 80C.
Primary antibodies were cross-linked to Protein G-coated Dynabeads (Invi-
trogen). Briefly, the beads were washed in citrate-phosphate buffer (pH 5.4)
and incubated with constant mixing for 1 hr at RT in the same buffer containing
a mouse antibody to p38 (Sigma), affinity-purified rabbit anti-VGLUT2
(Synaptic Systems), affinity-purified rabbit anti-VMAT2 (Pel-Freez), affinity-
purified rabbit anti-golgi matrix protein 130 (Abcam), or no primary antibody.
The beads were thenwashed in citrate-phosphate buffer, twice in 200mM trie-
thanolamine (pH 8.4), resuspended in 200 mM triethanolamine containing
20 mM dimethylpimelimidate, and cross-linked for 30 min at RT, again with
constant mixing. The crosslinking was stopped by resuspension in 50 mM
Tris (pH 7.5), and the beads were rinsed several more times with PBS contain-
ing protease inhibitors (PBS/PI). For immunoisolation, the beads were resus-
pended in PBS/PI containing 0.5% BSA, incubated with 300 mg synaptic
vesicle protein for 1.5 hr at RT with constant mixing, washed in PBS/PI and
resuspended in sample buffer for immunoblotting with rabbit anti-VMAT2Neuron 65, 643–656, March 11, 2010 ª2010 Elsevier Inc. 653
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Glutamate Corelease from Dopamine Neurons In Vivo(1:1000) or anti-VGLUT2 (1:2000), followed by HRP-conjugated TrueBlot anti-
rabbit antibody at 1:5000 (eBiosciences) and detection by enhanced chemilu-
minescence.
Vesicular Transport and Acidification
HEK293T cells were transfected by calcium phosphate with 18.75 mg VMAT2
cDNA ± 37.5 mg VGLUT2 cDNA per 15 cm plate. 48 hr after transfection, cells
were harvested, pelleted, resuspended in 140 mM choline gluconate contain-
ing 10 mM HEPES-Tris (pH 7.4), and sonicated on ice. The lysate was centri-
fuged for 5 min at 16,000 rpm at 4C, and the supernatant used for transport
assays. Spun columns were prepared by swelling Sephadex G50-fine (Sigma)
in choline gluconate buffer (140 mM choline gluconate, 10 mM HEPES-Tris,
2 mM KCl) for >3 hr before loading into 1 ml syringe barrels with Whatman
GF/A filter paper support, and then prespinning at 2700 3 g for 2 min. Uptake
was performed by adding lysate (10–50 mg protein) to 160 ml reaction mix that
contains 150 mM choline gluconate, 10 mM HEPES-Tris (pH 7.4), 2 mM
MgATP, 2 mM KCl, 89 nM H35-HT, and 10 mM K-aspartate or 10 mM K-gluta-
mate ± 10 mM reserpine, incubating for 5 min at 30C, transferring 140 ml to the
top of the column, spinning again for 2 min, and measuring the radioactivity in
100 ml of the eluate using 5 ml Cytoscint (ICN) and a Beckman scintillation
counter.
Ventral striata (olfactory tubercle, NAc shell, and core) were dissected from
3-week-old rat brains, and LP2 isolated from ventral striatum or the rest of the
brain as previously described (Hell and Jahn, 1994). To measure transport,
30–100 mg ventral striatum LP2 was incubated for 10 min at 30C in 200 ml
reaction mix (described above), the entire reaction volume filtered through
200 mmDuraPore filters (Millipore), washed 3 times with 1.5 ml ice-cold choline
gluconate buffer, and counts measured as above.
Tomeasure acidification, 1.5ml of 5 mMacridine orange in choline gluconate
buffer was pre-incubated for >5 min at 30C with constant stirring in a F4500
fluorescence spectrophotometer (Hitachi). For each run, 150 mg forebrain LP2
was added first, followed by 1 mM Mg2+ATP, 2 mM choline Cl, and variable
concentrations of choline glutamate, choline aspartate, and/or choline Cl,
sometimes followed by addition of 250 nM bafilomycin (Calbiochem) and/or
50 nM valinomycin (Sigma). Acidification was replicated at least three times
for each condition. To quantify the magnitude and rates of fluorescence
change, curves were fit to linear or single exponential plots and values
extracted using SigmaPlot and SigmaStat (Systat).SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2010.02.012.
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